Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 433-434, September 2009

Commentary on “Alzheimer's disease drug development and the problem of the blood-brain barrier”

  • James W. Simpkins

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 817-735-0498; Fax: 817-735-2091.

Department of Pharmacology and Neuroscience, Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, TX, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by grants AG10285, AG22550, and AG027956 from the National Institutes of Health.

PII: S1552-5260(09)02091-3

doi:10.1016/j.jalz.2009.06.004

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 5 , Pages 433-434, September 2009

Article Tools